As the respiratory virus season comes to an end in the United States, it's important to note that the majority of influenza and respiratory syncytial virus (RSV) vaccines were administered by pharmacists in 2023 and 2024.
Despite dealing with their traditional flu shot workload, pharmacists had to administer new RSV vaccines, leaving them frustrated with the lack of time to consult with patients.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
